Idarubicin Hydrochloride
Who holds supplier records for Idarubicin Hydrochloride? 2 organisations hold a current record for Idarubicin Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Switzerland (1) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Idarubicin Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/idarubicin-hydrochloride
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Idarubicin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- SYNBIAS PHARMA AGSwitzerlandActive DMF 17504, 36526 · latest filing Dec 2021
- TAPI NL BVNetherlandsActive DMF 13884 · latest filing Dec 1998
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Idarubicin Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- China · Inactive DMF 19613 · filed Jul 2006
- EXOPHARM CO LTDInactive DMF 19185 · filed Feb 2006
- United States · Inactive DMF 16057 · filed Jul 2002
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Idarubicin Hydrochloride is an anthracycline antineoplastic used in the treatment of certain types of cancer, including acute myeloid leukemia. It works by intercalating DNA, thereby inhibiting the synthesis of nucleic acids and causing cell death.
Chemical identity
- IUPAC name
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- Canonical SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl
- InChIKey
- JVHPTYWUBOQMBP-RVFAQHLVSA-N
- Synonyms
- Idamycin API, idamycin, idarubicin hcl, imi 30, imi-30, nsc-256439
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anthracycline Topoisomerase Inhibitor
- Mechanism of action
- Topoisomerase Inhibitors
- Chemical structure
- Anthracyclines
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Idarubicin Hydrochloride?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for Idarubicin Hydrochloride: SYNBIAS PHARMA AG (Switzerland) and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Idarubicin Hydrochloride Drug Master Files are active?
SYNBIAS PHARMA AG (DMF 17504, 36526) and TAPI NL BV (DMF 13884). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Idarubicin Hydrochloride records mean?
3 organisations have only inactive Type II DMFs for Idarubicin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Idarubicin Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Idarubicin Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.